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Abstract 
Aim: To find out whether bean extract has effects on levels of LDL and Ox-LDL and relation of Ox-LDL on 
LOX-1 gene polymorphism 3'UTR188CT. 
Method: This research is true randomized experiment  with a pretest - posttest  design  and control group. 
Samples were 35 subjects divided into 4 groups. Laboratory experiments using bean extract test affects LDL and 
plasma levels of Ox-LDL by Enzyme -linked Immunosorbent Assay (ELISA), test LOX-1 gene polymorphism 
3'UTR188CT with restriction enzyme. To evaluate effect of bean extract to LDL and Ox-LDL level were 
compared with unpaired t-test. To evaluate difference of Ox-LDL level on LOX-1 gene polymorphism 
3'UTR188CT using ANOVA. Results: There was a decrease of LDL found in all treatment groups and elevated 
levels of Ox-LDL. TT genotype had higher levels of plasma Ox-LDL both before (49,9 ± 8,3 vs. CC 39.9 ± 19.4 
and CT 42,8 ± 61,2,p .648 ) and after treatment (60.3 ± 5.7 vs. CC 55.93 ± 12.6 and CT 53.9 ± 10.3, p .630) than 
other genotype.Conclusion: Bean extract can lower LDL cholesterol although it can also increased plasma level 
of Ox-LDL. TT genotype had higher levels of plasma Ox-LDL than other genotypes. Require further study to 
other antioxidants may have a beneficial effect by lowering the levels of Ox-LDL. 
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1. Introduction 
Atherosclerosis is a chronic inflammation of the blood vessels, which would lead to the emergence of atherom 
plaque, a focal lesion located in the intima of the blood vessels. Cardiovascular disease is the leading cause of 
death in most developed countries. Most deaths from cardiovascular disease can be prevented through lifestyle 
changes such as diet, exercise, and stop smoking (Anderson et al. 2002; Pirillo et al. 2013; Packard et al. 2008; 
Anderson et al. 1999; Bazzano et al. 2001). 
Initiating event in atherosclerosis is the change LDL into oxidized LDL (Ox-LDL) by several factors such as 
radicals, lypooxygenation, causing splitting of fatty acids that are not saturated into the LDL particle. Ox-LDL 
activity will be mediated by different receptors known as scavenger receptors (SR), such as SR-AI/II, SR-BI, 
CD36, MARCO, marcosialin (CD68) and lectin-like oxidized low-density lipoproteins receptor-1 (LOX-1). 
Sawamura et al, first to identify LOX-1 as a major receptor for endothelial cells in Ox-LDL (Dunn et al. 2008; 
Kurnaz et al. 2011). Mango et al, delivers up to now there are 7 polymorphisms that have been identified in the 
LOX-1 gene. One of them is 3'UTR188CT (Kurnaz et al. 2011; Chen et al. 2000; Chen et al. 2001; Chen et al. 
2003; Reiss et al. 2009; Mango et al. 2003).
 
Consumption of leguminous plants that have been known to contain lots of protein and water-soluble fiber may 
reduce the risk of coronary heart disease (Bazzano et al. 2011). Beans (Phaseolus vulgaris L) are a type of 
legume that has been known to have a lowering lipid profile and diuretic effect. Mackay, et al., conducted the 
study with the addition of 80 grams of beans in the daily diet, obtained an increase in HDL cholesterol compared 
with no beans in the diet (Kabagambe et al. 2005; Hansen D, 2005; Winhan et al. 2007; Mackay et al. 1992).
  
Based on the above description, research on the effect of extract beans to LDL and Ox-LDL and relation of Ox-
LDL on LOX-1 gene polymorphism 3'UTR188CT, as preventive risk of atherosclerosis has not been 
investigated. Therefore this study will find out whether extract bean has effects on levels of LDL and Ox-LDL 
and relation of Ox-LDL on LOX-1 gene polymorphism 3'UTR188CT.  
 
2. Material and Methods 
This study is true randomized experiment with a pretest - posttest design with control group.          
2.1 Subjects 
Subjects were paramedics at Putri Hijau Hospital, Medan. 40 participants were recruited with inclusion criteria: 
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1. Normal subjects both men and women aged 30-50 years. 2. Have a complete personal data such as name, 
address, age, and phone number, or mobile phones. 3. Willing to participate in the study and signed a consent 
form after getting a description of the study (informed consent). Exclusion criteria : 1. Suffering hypertension, 
diabetes mellitus (DM), and impaired renal function 2. Intolerance to nuts. Drop out criteria : 1. If during the 
period of the study subjects died or refused to continue the research. 2. If during the study subjects did  not  
consume  bean  extract  that  has  been  established  or  suffering severe illness. 
2.2 Treatment 
Subjects underwent pre treatment for one week (baseline period, starting from H – 6 to  day 0), with dietary 
habits such as usual and asked not to  consume any kind  of food that comes from the nuts. 
On day 0, patients  underwent  blood  sampling for  examination  LDL, Ox-LDL  levels and LOX-1 gene 
polymorphism 3'UTR188CT. Subjects get an explanation about the dosage and how to take the extract. 
Treatments from day 0, subjects were divided into four groups. The first group (A) consumed beans every day as 
much as 40 grams per  day were made in  the capsule, the second  group (B) 80 grams, the third  group (C) 120  
grams, while  the  fourth  group (D)  taking placebo. Consumption schedule  is  while  eating. Subjects  will  also  
call  or  send  short  messages service/SMS via mobile phone to remind drinking extract schedule. 
2.3 Blood test 
Blood samples (Whole Blood) is taken when the study participants were in fasting 10-12 hours using a 10 cc 
syringe already containing anticoagulant (heparin) on the vein by a trained nurse. The blood sample is then sent 
to a laboratory for examination of LDL (Multigent Architect), Ox-LDL levels (Mercodia, 2003) and LOX-1 gene 
polymorphism 3'UTR188CT (PCR - RFLP method) (Noviyanti et al. 2007).
 
2.4 Statistical analysis 
LDL and Ox-LDL level data were normally distributed. To evaluate effect of bean extract to LDL and Ox-LDL 
level were compared with unpaired t-test. To evaluate difference of  Ox-LDL level on LOX-1 gene 
polymorphism 3'UTR188CT using ANOVA. We considered a value of p<0.05 as significant. Data analyses were 
performed by using SPSS 16.0.  
   
3. Result 
From 40 subjects who were willing to follow the study, there were 5 subjects drop out because not consume 
capsules as has been suggested. The fifth subject is from Group A 1 subject, 3 subjects in group C and group D 1 
subject, bringing the total study participants who completed the study 35 study subjects.  
Of the 35 subjects, most subjects  were women  27 subjects (77%) and  men  8   subjects (23%). The  baseline 
characteristics of the subjects by study group can be seen in Table 1. 
Table 1. The baseline characteristics of the subjects by study group 
Characteristic Bean extract  
40 g (N=9) 
Bean extract 
80 g (N=10) 
Bean extract 
120 g (N=7) 
Placebo 
(N=9) 
Sex female – no (%) 7 (78) 8 (80) 6 (86) 6 (67) 
Old - years 43 ± 4,6* 38,2 ± 5,3** 44,43 ± 4,6*** 38,78 ± 5,2 
Blood sugar 87 ± 8,7 87,7 ± 8,2 80 ± 7,6 86,78 ± 7 
Ureum 20,89 ± 5,6 20,8 ± 5,6 19,43 ± 2,4 18,22 ± 4,6 
Creatinin 0,84 ± 0,26 0,81 ± 0,26 0,76 ± 0,16 0,83 ± 0,18 
Hypertension – no (%) - - - - 
Dyslipidaemia – no (%) 6 (67) 5 (50) 4 (57) 3 (33) 
* p <0.05 compared to extract 80 g 
** p <0.05 compared to extract 40 g and 120 g 
*** p <0.05 compared to extract 80 g and placebo 
From  the  above  table  it  can  be seen that the only significant difference was age between subjects  who  
consumed  the  extract 40 g / day to 80 g / day,  80 g / day to 120 g / day  and between 120 g / day with placebo. 
From 35  subjects  examined  LOX-1 gene  polymorphisms that  have  gained 3'UTR188CT CC  genotype as 
many as 15 subjects (43%), CT 17 subjects (49%) and TT 3 subjects (8%). Test results  of LOX-1 gene  
polymorphism 3'UTR188CT based study group can be seen in the figure 1 below. 
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Figure 1. Test results  of LOX-1 gene  polymorphism 3'UTR188CT based study group 
From  35 subjects   who  had a C  allele  were 47 (67%) and  T alleles were  23 (33%) that  can  be seen  in the 
figure 2 below. 
 
Figure 2.Allele frequency based on study group 
From figure 2, it can be seen that the C allele had a greater frequency than T allele in all groups. 
TT genotype had higher levels of Ox-LDL plasma than other genotypes both before and after treatment that can 
be seen in the table below 
Table 2. Ox-LDL plasma levels before treatment based on gene polymorphisms LOX-1 3'UTR188CT 
Parameter N Ox-LDL  p 
CC 15 39.9 ± 19.4  
0.648 
CT 17 42,8 ± 61,2 
TT 3 49,9 ± 8,3 
Table 3. Ox-LDL plasma levels after treatment based on gene polymorphisms LOX-1 3'UTR188CT 
Parameter N Ox-LDL  p 
CC 15 55.93 ± 12.6  
0.630 CT 17 53.9 ± 10.3 
TT 3 60.3 ± 5.7 
 
When compared LDL and Ox-LDL   plasma level before and after treatment, the results can be seen in the figure 
3 below. 
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) 
Vol.4, No.11, 2014 
 
30 
 
                  Figure 3. Comparison results of  LDL and Ox-LDL plasma level before and after treatment 
From figure 3, it can be seen that the LDL cholesterol decreased in all group gave extract, although  not  
significantly. In group B and  group C  found  increased  plasma  Ox-LDL were significant after treatment. 
 
4. Discussion  
Phytochemical screening results simplisia beans containing the compound identified as alkaloids, saponin, 
flavonoid, triterpenoid/steroid, and glycoside (data not shown). The phytochemical test results show that beans 
extract do not contain some crude drug material owned by the bean itself like folate, fibre, arginine, amino acid, 
asparagines, kholina, tannin, fasin, starch, vitamin A, vitamin C, and minerals (copper, calcium, magnesium, iron, 
potassium) (Hansen D, 2005). 
This study found that plasma levels of Ox-LDL increase after giving bean extract. Possibility of that situation 
because bean extract not contain complete compound as content materials or substances contained in the beans 
themselves, such as fibre. Meta-analysis conducted by Brown et al, found that soluble fibre can significantly 
lower total cholesterol and LDL. Mechanism of fibre can lower cholesterol: the ligament fibres with intra-
luminal cholesterol during its formation inhibiting the formation of hepatic fatty acid with the production of 
short chain fatty acids such as acetate, butyrate, and propionate; alter intestinal motility; slowing the absorption 
of macronutrients resulting in increased insulin sensitivity and increase the feeling of satiety as a whole will 
reduce input (Brown et al. 1999). In addition to fibre, the substance that also contributes to lowering cholesterol 
but not present in the extract is folate, and vitamin A (Jeyakumar et al. 2007). 
Results of this study also found reduction in LDL cholesterol in all groups were given the extract of beans, but 
also found increase in plasma levels of Ox-LDL. This suggests that although LDL cholesterol can be lowered but 
not automatically Ox - LDL plasma levels will go down well. This result is also in line with research conducted 
by Fang et al and Silante et al (Fang et al. 2011; Silaste et al. 2004). 
Increased plasma levels of Ox - LDL is also known to be temporary. Naruko et al, reported an increase in plasma 
levels of Ox-LDL in patients with acute myocardial infarction of approximately 3.5 times compared to normal 
subjects. But the increase in plasma levels of Ox-LDL then down to near normal level when the patient is 
discharged from the hospital. The same result was obtained by Uno et al, who observed plasma levels of Ox-
LDL in patients with cerebral infarction. Ox-LDL plasma levels of patients with cerebral infarction will increase 
in the days of the first occurrence of the disease and returned to the normal range within 30 days (Itabe et al. 
2007; Itabe et al. 2011; Naruko et al. 2006; Uno et al. 2003).
 
Another possibility to elevated levels of Ox-LDL after consuming bean extract is an antioxidant found in beans 
extract does not contain sufficient antioxidant activity. It is also said by Silaste et al, who conducted the study 
with administration of a diet low in fat, low in vegetables, and low-fat diet, high vegetable found an increased 
Ox-LDL by 27% and 9% sequentially. Another possibility is that because it is not clear how the oxidation of 
LDL occurs in vivo, trials in humans may be used the wrong anti-oxidant (Silaste et al. 2004).
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Results of this study also found that participants with the TT genotype had higher levels of Ox-LDL compared to 
participants with CC and CT genotypes. As has been mentioned before, that the Ox-LDL levels will be elevated 
in patients with cardiovascular disorders so that participants with genotype TT has the possibility for the 
occurrence of cardiovascular disorders higher than the other genotypes. This is in line with the study conducted 
by Mango et al, while found that participants with the CT or TT genotype had a greater risk for the development 
of acute myocardial infarction (Mango et al. 2003).
 
 
5. Conclusion 
We found that bean extract can lowering LDL but not Ox-LDL. Require further study to other antioxidants may 
have a beneficial effect by lowering the levels of Ox-LDL. 
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